ARTICLE | Distillery Therapeutics
Cancer
January 23, 2019 12:07 AM UTC
In silico and mouse studies identified a synthetic protein agonist of IL2RB and IL2RG that could help treat melanoma and colorectal cancer with less toxicity than IL-2. Computational modeling of inter...